Skip to content

Advertisement

Articles

Page 3 of 6

  1. Content type: Research

    Since its inception, the Uganda National Drug Authority (NDA) has regularly inspected private sector pharmacies to monitor adherence to Good Pharmacy Practices (GPP). This study reports findings from the first...

    Authors: Birna Trap, Kate Kikule, Catherine Vialle-Valentin, Richard Musoke, Grace Otto Lajul, Kim Hoppenworth and Dorthe Konradsen

    Citation: Journal of Pharmaceutical Policy and Practice 2016 9:18

    Published on:

  2. Content type: Research

    India shoulders the greatest global burden of cardiovascular diseases (CVDs), which are the leading cause of mortality worldwide. Drugs are the bedrock of treatment and prevention of CVD. India’s pharmaceutica...

    Authors: Charles Newman, Vamadevan S. Ajay, Ravi Srinivas, Sandeep Bhalla, Dorairaj Prabhakaran and Amitava Banerjee

    Citation: Journal of Pharmaceutical Policy and Practice 2016 9:16

    Published on:

  3. Content type: Letter to the Editor

    Exorbitant price increases for critical off-patent medicines have received considerable media attention in recent months, leading to an investigation by the U.S. Senate. However, much of this attention has foc...

    Authors: Adam R. Houston, Reed F. Beall and Amir Attaran

    Citation: Journal of Pharmaceutical Policy and Practice 2016 9:15

    Published on:

  4. Content type: Research

    Consumers are hesitant in choosing generic medications as they are under the assumption that they are not as safe nor effective as brand medications. However, pharmacists do have the education and training to ...

    Authors: Mira Patel, Marion Slack, Janet Cooley and Sandipan Bhattacharjee

    Citation: Journal of Pharmaceutical Policy and Practice 2016 9:17

    Published on:

  5. Content type: Commentary

    Achieving increased access to medicines in low- and middle-income countries is a complex issue that requires a holistic approach. Choosing an appropriate manufacturing strategy that can ensure a sustainable su...

    Authors: Mutsumi Metzler and Patricia S. Coffey

    Citation: Journal of Pharmaceutical Policy and Practice 2016 9:14

    Published on:

  6. Content type: Commentary

    Despite the high level of spending on cancer medicines in Australia, consumer organisations and the pharmaceutical industry often make claims of delayed or lack of access to new cancer medicines—claims that ar...

    Authors: Agnes Vitry, Barbara Mintzes and Wendy Lipworth

    Citation: Journal of Pharmaceutical Policy and Practice 2016 9:13

    Published on:

  7. Content type: Research

    Many patients even those with health insurance pay out-of-pocket for medicines. We investigated the availability and prices of essential medicines in the Boston area.

    Authors: Abhishek Sharma, Lindsey Rorden, Margaret Ewen and Richard Laing

    Citation: Journal of Pharmaceutical Policy and Practice 2016 9:12

    Published on:

  8. Content type: Research

    A wide range of pharmaceutical products are needed for diagnosis, treatment, and prevention of HIV/AIDS. However, interrupted supplies and stock-outs are the major challenges in the supply chain of ARV medicin...

    Authors: Eyerusalem Berhanemeskel, Gebremedhin Beedemariam and Teferi Gedif Fenta

    Citation: Journal of Pharmaceutical Policy and Practice 2016 9:11

    Published on:

  9. Content type: Research

    Antibiotic resistance is a serious global public health problem directly correlated to high antibiotic consumption. Romania is one of the European countries with the highest rates of antibiotic consumption, no...

    Authors: I. Ghiga and C. Stålsby Lundborg

    Citation: Journal of Pharmaceutical Policy and Practice 2016 9:10

    Published on:

  10. Content type: Editorial

    In October 2015, the third international Pharmaceutical Pricing and Reimbursement Information (PPRI) Conference was held in Vienna to foster discussion on challenges in pricing and reimbursement policies for m...

    Authors: Sabine Vogler, Nina Zimmermann, Alessandra Ferrario, Veronika J. Wirtz, Kees de Joncheere, Hanne Bak Pedersen, Guillaume Dedet, Valérie Paris, Aukje K. Mantel-Teeuwisse and Zaheer-Ud-Din Babar

    Citation: Journal of Pharmaceutical Policy and Practice 2016 9:9

    Published on:

  11. Content type: Research

    Financial recession mandated the introduction of harsh austerity measures. Health, and particularly pharmaceuticals, constitute a significant part of public expenditure and as such they have been subject to si...

    Authors: Panagiotis Petrou and Michael A. Talias

    Citation: Journal of Pharmaceutical Policy and Practice 2016 9:8

    Published on:

  12. Content type: Research

    Clinical pharmacy service has evolved steadily over the past few decades and is contributing to the ‘patient care journey’ at all stages. The service improves safety and effectiveness of medicines, thereby avo...

    Authors: Arebu Issa Bilal, Zelalem Tilahun, Gebremedhin Beedemariam, Belete Ayalneh, Bisrat Hailemeskel and Ephrem Engidawork

    Citation: Journal of Pharmaceutical Policy and Practice 2016 9:7

    Published on:

  13. Content type: Research

    Ghana established its National Health Insurance Scheme (NHIS) in 2003 with the goal of ensuring more equitable financing of health care to improve access to health services. This qualitative study examines the...

    Authors: Paul G. Ashigbie, Devine Azameti and Veronika J. Wirtz

    Citation: Journal of Pharmaceutical Policy and Practice 2016 9:6

    Published on:

  14. Content type: Research

    Clinical trials showed a higher risk of skin- and liver- related adverse reactions when NVP-based antiretroviral therapy (ART) was initiated in female and male patients with baseline CD4 cell counts ≥250 and ≥...

    Authors: Francis Kalemeera, Assegid T. Mengistu and Johannes Gaeseb

    Citation: Journal of Pharmaceutical Policy and Practice 2016 9:5

    Published on:

  15. Content type: Research

    Little is known about the perceived attitude, barriers and facilitators of Saudi Pharmacists about practice based research. We aimed to measure the attitude, barriers, and facilitators of Saudi hospital pharma...

    Authors: Khizra Sultana, Majed Al Jeraisy, Maha Al Ammari, Rahul Patel and Syed Tabish R. Zaidi

    Citation: Journal of Pharmaceutical Policy and Practice 2016 9:4

    Published on:

  16. Content type: Research

    This scoping review investigates the relationship between governance, pharmacovigilance, and Agencia Nacional de Vigilancia Sanitaria (ANVISA) in Brazil, which has authority over Brazil's national pharmaceutic...

    Authors: Kathy Moscou, Jillian C. Kohler and Anita MaGahan

    Citation: Journal of Pharmaceutical Policy and Practice 2016 9:3

    Published on:

  17. Content type: Research

    As medicines are becoming more targeted and complex in the U.S., ensuring patients’ safe use of medications with known dangerous risks is critical for public health and safety. Therefore, the Risk Evaluation a...

    Authors: Stacey L. Worthy

    Citation: Journal of Pharmaceutical Policy and Practice 2016 9:2

    Published on:

  18. Content type: Research

    The increasing prevalence of chronic diseases puts a high burden on the health care systems of Low and Middle Income Countries which are often not adapted to provide the care needed. Peer support programmes ar...

    Authors: Josefien van Olmen, Natalie Eggermont, Maurits van Pelt, Heang Hen, Jeroen de Man, François Schellevis, David H. Peters and Maryam Bigdeli

    Citation: Journal of Pharmaceutical Policy and Practice 2016 9:1

    Published on:

  19. Content type: Erratum

    Authors: Edmund Rutta, Jafary Liana, Martha Embrey, Keith Johnson, Suleiman Kimatta, Richard Valimba, Rachel Lieber, Elizabeth Shekalaghe and Hiiti Sillo

    Citation: Journal of Pharmaceutical Policy and Practice 2015 8:29

    Published on:

    The original article was published in Journal of Pharmaceutical Policy and Practice 2015 8:23

  20. Content type: Research

    The Nigerian health sector battles with control of infectious diseases and emerging non-communicable diseases. Number of healthcare personnel involved in public health programs need to be boosted to contain th...

    Authors: Ogochukwu Offu, Maureen Anetoh, Matthew Okonta and Obinna Ekwunife

    Citation: Journal of Pharmaceutical Policy and Practice 2015 8:27

    Published on:

  21. Content type: Research

    The irrational use of reserved antimicrobials, such as ceftriaxone, is one of the global public health issues particularly to low income countries like Ethiopia, leading to high costs of treatment or therapeut...

    Authors: Tariku Shimels, Arebu I Bilal and Anwar Mulugeta

    Citation: Journal of Pharmaceutical Policy and Practice 2015 8:26

    Published on:

  22. Content type: Review

    Some humanitarian and development organizations respond to major natural disasters and emergencies by donating medicines. Many provide medicines on a routine basis to support health systems, particularly those...

    Authors: Nuria Cañigueral-Vila, Jennifer C. Chen, Lindsey Frenkel-Rorden and Richard Laing

    Citation: Journal of Pharmaceutical Policy and Practice 2015 8:28

    Published on:

  23. Content type: Research

    Withdrawal of conditional regulatory approval or subsidization of new medicines when subsequent evidence does not confirm early trial results may not be well understood or accepted by the public.

    Authors: Agnes Vitry, Tuan Nguyen, Vikky Entwistle and Elizabeth Roughead

    Citation: Journal of Pharmaceutical Policy and Practice 2015 8:25

    Published on:

  24. Content type: Review

    Hypertension is the leading modifiable cause of mortality worldwide. Unlike many conditions where limited evidence exists for management of older individuals, multiple large, robust trials have provided a soli...

    Authors: Tariq M Alhawassi, Ines Krass and Lisa G Pont

    Citation: Journal of Pharmaceutical Policy and Practice 2015 8:24

    Published on:

  25. Content type: Poster presentation

    Authors: Roberta Joppi, Elisa Cinconze, Luca Demattè, Renato Guseo, Claudio Jommi, Cinzia Mortarino, Daniela Pase, Chiara Poggiani, Alessandro Roggeri and Daniela Roggeri

    Citation: Journal of Pharmaceutical Policy and Practice 2015 8(Suppl 1):P9

    Published on:

    This article is part of a Supplement: Volume 8 Supplement 1

Annual Journal Metrics

Advertisement